4.0 Article

Old Drugs for New Purpose-Fast Pace Therapeutic Identification for SARS-CoV-2 Infections by Pharmacophore Guided Drug Repositioning Approach

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study

Sourav Das et al.

Summary: This study used a blind molecular docking approach to identify potential inhibitors of the SARS-COV-2 main protease, with rutin showing the highest inhibitor efficiency. All studied molecules were able to bind to the active site of the main protease and were surrounded by other active site residues. Further wet-lab experimentation and clinical trials are needed for validation.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Letter Biochemistry & Molecular Biology

Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: anin silicobased approach

Saurov Mahanta et al.

Summary: The study identified Viomycin as a potential inhibitor of the Main Protease of SARS-CoV-2, showing higher -CDocker energy and forming more hydrogen bonds with the protein compared to drugs like Ritonavir and Lopinavir currently under clinical trial. Molecular dynamics simulation suggested that Viomycin had strong binding with the Main Protease, indicating its potential as a treatment option for the pandemic.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Biochemistry & Molecular Biology

Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease

Rakesh S. Joshi et al.

Summary: The study indicates structural divergence of the main protease (M-Pro) within the Coronaviridae family but with conserved structural features. Researchers identified several natural molecules, such as delta-viniferin, myricitrin, that strongly bind to SARS-CoV-2 M-Pro and other potential targets. This approach of multi-target-directed ligand identification may provide new avenues for drug discovery against SARS-CoV-2 infection.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Biochemistry & Molecular Biology

Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease -in silicoapproach

Vankudavath Raju Naik et al.

Summary: The 2019 novel coronavirus is a highly infectious and deadly virus without effective treatment options. In this study, computational methods were used to analyze the sequence, structure, and molecular docking of the M(pro) protein of 2019-nCOV. The results suggest that Remdesivir may be a potent therapeutic inhibitor against 2019-nCoV, with strong binding affinity and stable interactions with key residues of the M(pro) protein.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Review Immunology

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

Hussin A. Rothan et al.

JOURNAL OF AUTOIMMUNITY (2020)

Article Chemistry, Multidisciplinary

Discovery of Lonafarnib-Like Compounds: Pharmacophore Modeling and Molecular Dynamics Studies

Shailima Rampogu et al.

ACS OMEGA (2020)

Article Biochemistry & Molecular Biology

Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design

Maria Bzowka et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Multidisciplinary Sciences

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Zhenming Jin et al.

NATURE (2020)

Letter Biochemistry & Molecular Biology

The proximal origin of SARS-CoV-2

Kristian G. Andersen et al.

NATURE MEDICINE (2020)

Article Medicine, General & Internal

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19

B. Cao et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Pharmacology & Pharmacy

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

Leon Caly et al.

ANTIVIRAL RESEARCH (2020)

Review Pharmacology & Pharmacy

Discovering small-molecule therapeutics against SARS-CoV-2

Vaibhav Tiwari et al.

DRUG DISCOVERY TODAY (2020)

Article Medicine, Research & Experimental

Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease

Mahmoud Kandeel et al.

LIFE SCIENCES (2020)

Article Infectious Diseases

Paromomycin: A potential dual targeted drug effectively inhibits both spike (S1) and main protease of COVID-19

Asma Tariq et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Article Biochemistry & Molecular Biology

Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography

Daniel W. Kneller et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Article Multidisciplinary Sciences

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease

Alice Douangamath et al.

NATURE COMMUNICATIONS (2020)

Letter Biochemistry & Molecular Biology

A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2

Zhe-Rui Zhang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Biochemistry & Molecular Biology

Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model

Bo Ram Beck et al.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)

Review Chemistry, Multidisciplinary

Computer-Aided Drug Design in Epigenetics

Wenchao Lu et al.

FRONTIERS IN CHEMISTRY (2018)

Review Veterinary Sciences

Coronaviruses in avian species - review with focus on epidemiology and diagnosis in wild birds

Justyna Milek et al.

JOURNAL OF VETERINARY RESEARCH (2018)

Review Multidisciplinary Sciences

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase

Yousuke Furuta et al.

PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2017)

Article Multidisciplinary Sciences

Molecular mechanism of viomycin inhibition of peptide elongation in bacteria

Mikael Holm et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Chemistry, Medicinal

Role of computer-aided drug design in modern drug discovery

Stephani Joy Y. Macalino et al.

ARCHIVES OF PHARMACAL RESEARCH (2015)

Article Biology

CORONAVIRUS GENOMICS AND BIOINFORMATICS ANALYSIS

Patrick C. Y. Woo et al.

OMICS IN CLINICAL PRACTICE: GENOMICS, PHARMACOGENOMICS, PROTEOMICS, AND TRANSCRIPTOMICS IN CLINICAL RESEARCH (2014)

Article Chemistry, Multidisciplinary

SwissParam: A Fast Force Field Generation Tool for Small Organic Molecules

Vincent Zoete et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)

Review Biochemistry & Molecular Biology

Coronaviruses An RNA proofreading machine regulates replication fidelity and diversity

Mark R. Denison et al.

RNA BIOLOGY (2011)

Review Virology

Coronavirus Genomics and Bioinformatics Analysis

Patrick C. Y. Woo et al.

VIRUSES-BASEL (2010)

Review Chemistry, Multidisciplinary

GROMACS: Fast, flexible, and free

D Van der Spoel et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)

Review Pediatrics

SARS: the first pandemic of the 21st century

JD Cherry et al.

PEDIATRIC RESEARCH (2004)

Article Chemistry, Multidisciplinary

UCSF chimera - A visualization system for exploratory research and analysis

EF Pettersen et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)

Article Multidisciplinary Sciences

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

HT Yang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)